Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Endocrine Neoplasia Type 1”

312 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 312 results

Not applicableEnrolling By InvitationNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT04267263
What this trial is testing

A Novel Approach to Reducing Adiposity Among Young Men

Who this might be right for
Weight LossMenLifestyle Risk Reduction+2 more
Virginia Commonwealth University 35
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Not applicableStudy completedNCT01928134
What this trial is testing

The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis

Who this might be right for
Healthy
Changhua Christian Hospital 60
Early research (Phase 1)Study completedNCT05061563
What this trial is testing

Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 14
Early research (Phase 1)Study completedNCT05071729
What this trial is testing

Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Bayer 31
Not applicableUnknownNCT03262129
What this trial is testing

Type 1 Multiple Endocrine Neoplasia Cohort Study

Who this might be right for
Type 1-Multiple Endocrine Neoplasia Syndrome
Centre Hospitalier Universitaire Dijon 2,000
Not applicableStudy completedNCT03046641
What this trial is testing

Exercise Duration Models, in Middle-aged Men

Who this might be right for
Weight Loss
P.L.Shupik National Medical Academy of Post-Graduate Education 82
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07444723
What this trial is testing

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Who this might be right for
Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 193
Not applicableStudy completedNCT02932384
What this trial is testing

Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness

Who this might be right for
HIVMen
Charles Drew University of Medicine and Science 105
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Not applicableStudy completedNCT03339154
What this trial is testing

Metabolic Availability of Methionine From Chickpeas in Adult Men

Who this might be right for
Healthy
The Hospital for Sick Children 6
Not applicableStudy completedNCT06629220
What this trial is testing

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

Who this might be right for
Suicide PreventionSuicidal IdeationSuicidal Behaviour
University Ghent 13
Testing effectiveness (Phase 2)Study completedNCT02101918
What this trial is testing

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Multiple Endocrine Neoplasia Type 1Pancreatic Neuroendocrine Carcinoma
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT00816764
What this trial is testing

The Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Who this might be right for
CarcinomaOvarian CancerOvarian Diseases+1 more
Astellas Pharma Inc 18
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Next Page